Document is current
Any future updates will be listed below
-
Authors
Ding, Hao
Deng, Yan
Zeng, Rong
Zhang, Guoqiao
Zheng, Qingqing
Fu, Qiaofen
Li, Rongqing
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82060486, 82160529, 82360462)
535 Talent Project of First Affiliated Hospital of Kunming Medical University (No. 2023535D17)
The Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University (Grant No. 202001AY070001-006)
- License Information
-
More Information
Article History
Received: 29 March 2025
Accepted: 7 October 2025
First Online: 31 October 2025
Declarations
:
: These experiments were also conducted according to established experimental protocols and were approved by the Animal Care and Use Committee of Kunming Medical University (Approval number: PZ20220305). The study is reported in accordance with the ARRIVE guidelines. In this study, our research team employed PEITC for interventional therapy in mice with subcutaneous tumorigenesis. The humane endpoints or termination criteria for the experiment were as follows: 1. The tumor weight did not exceed 10% of the animal’s body weight. 2. The tumor diameter did not exceed 17 mm. During the experimental process, the maximum tumor diameter observed was 10.43 mm, which is less than 17 mm. This did not exceed the ethical requirements and complied with ethical standards.
: Not applicable.
: Not applicable.
: The authors declare no competing interests.
